Patient Selection, Surgery and Perioperative Management in Lung Transplantation in Japan

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2024 May 13

PMID 38738216

Authors

Chihiro Konoeda

Masaaki Sato

Affiliations

Soon will be listed here.

Abstract

Lung transplantation (LT) is the final treatment option for end-stage respiratory diseases. The current prognosis of LT recipients in Japan is good, however, the reason for the good prognosis is unclear. In Japan, the waiting time for cadaveric LT is long, which is approximately 900 days on average. A long waiting time affects several aspects of LT. The diseases progress while they await LT in most patients are waiting for LT. Along with the disease progression of the disease, secondary pulmonary hypertension can newly emerge. Some patients suffer from refractory secondary pneumothorax and may receive pleurodesis. Transplant operations can become more difficult, and postoperative management becomes more complicated owing to the disease progression. Thoracic surgeons in Japan have managed the tough difficult situation of LT patients with LT. Possible explanations for how we to maintain a better prognosis in such a situation include sophisticated surgical techniques and ideas, and vigorous postoperative management by thoracic surgeons. Thoracic surgeons are vigorously involved both in operations and in postoperative management in the intensive care unit with or without intensivists in Japan. On the other hand, the long waiting time in Japan and allocation rules with age restriction without considering the severity of patients may have resulted in the selection of recipients to include relatively young recipients, fewer patients with interstitial lung disease and fewer recipients with extracorporeal membrane oxygenation (ECMO) as a bridge to LT. These recipients' characteristics possibly may have affected the prognosis of LT patients with LT in Japan. There is a chance that a future increase in the number of cadaveric donors in Japan may result in a prognosis close that is similar to the international average if the current waiting time in Japan decreases. We review patient selection, surgery and perioperative management in LT in Japan to address the question of why the current prognosis of LT recipients in Japan is good.

References

Chen-Yoshikawa T, Tanaka S, Yamada Y, Yutaka Y, Nakajima D, Ohsumi A . Intermediate outcomes of right-to-left inverted living-donor lobar lung transplantation. Eur J Cardiothorac Surg. 2019; 56(6):1046-1053. DOI: 10.1093/ejcts/ezz244. View

Date H . Living-Donor Lobar Lung Transplantation: How I Teach It. Ann Thorac Surg. 2021; 112(4):1055-1058. DOI: 10.1016/j.athoracsur.2021.06.051. View

Date H . Living-related lung transplantation. J Thorac Dis. 2017; 9(9):3362-3371. PMC: 5708411. DOI: 10.21037/jtd.2017.08.152. View

Yoshiyasu N, Sato M, Anraku M, Ichiba S, Nakajima J . Lung transplant after long-term veno-venous extracorporeal membrane oxygenation: a case report. J Cardiothorac Surg. 2021; 16(1):246. PMC: 8404359. DOI: 10.1186/s13019-021-01614-8. View

Atchade E, Ren M, Jean-Baptiste S, Tran Dinh A, Tanaka S, Tashk P . ECMO support as a bridge to lung transplantation is an independent risk factor for bronchial anastomotic dehiscence. BMC Pulm Med. 2022; 22(1):482. PMC: 9764472. DOI: 10.1186/s12890-022-02280-9. View

Di Nardo M, Tikkanen J, Husain S, Singer L, Cypel M, Ferguson N . Postoperative Management of Lung Transplant Recipients in the Intensive Care Unit. Anesthesiology. 2021; 136(3):482-499. DOI: 10.1097/ALN.0000000000004054. View

Boasquevisque C, Yildirim E, Waddel T, Keshavjee S . Surgical techniques: lung transplant and lung volume reduction. Proc Am Thorac Soc. 2009; 6(1):66-78. DOI: 10.1513/pats.200808-083GO. View

Shiiya H, Sato M . Lung Transplantation for Pleuroparenchymal Fibroelastosis. J Clin Med. 2021; 10(5). PMC: 7957581. DOI: 10.3390/jcm10050957. View

Crespo M . Airway complications in lung transplantation. J Thorac Dis. 2022; 13(11):6717-6724. PMC: 8662498. DOI: 10.21037/jtd-20-2696. View

10.

Arjuna A, Olson M, Walia R . Current trends in candidate selection, contraindications, and indications for lung transplantation. J Thorac Dis. 2022; 13(11):6514-6527. PMC: 8662491. DOI: 10.21037/jtd-2021-09. View

11.

Nakajima D, Tanaka S, Ikeda T, Baba S, Hiramatsu H, Suga T . Living-donor segmental lung transplantation for pediatric patients. J Thorac Cardiovasc Surg. 2022; 165(6):2193-2201. DOI: 10.1016/j.jtcvs.2022.07.031. View

12.

Miyoshi R, Chen-Yoshikawa T, Hamaji M, Kawaguchi A, Kayawake H, Hijiya K . Effect of early tracheostomy on clinical outcomes in critically ill lung transplant recipients. Gen Thorac Cardiovasc Surg. 2018; 66(9):529-536. DOI: 10.1007/s11748-018-0949-3. View

13.

Watanabe T, Okada Y, Adachi O, Sado T, Toyama H, Noda M . Contralateral pulmonary artery banding after single lobar lung transplantation. Ann Thorac Surg. 2014; 97(4):1429-31. DOI: 10.1016/j.athoracsur.2013.07.030. View

14.

Konoeda C, Sato M, Nagayama K, Nakajima J . Simultaneous single lobar lung transplantation and contralateral lung volume reduction. Eur J Cardiothorac Surg. 2020; 59(6):1342-1344. DOI: 10.1093/ejcts/ezaa459. View

15.

Shiiya H, Nakajima J, Date H, Chen-Yoshikawa T, Tanizawa K, Handa T . Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis. Surg Today. 2021; 51(8):1276-1284. DOI: 10.1007/s00595-021-02232-6. View

16.

Israni A, Zaun D, Gauntt K, Schaffhausen C, McKinney W, Miller J . OPTN/SRTR 2021 Annual Data Report: Deceased Organ Donation. Am J Transplant. 2023; 23(2 Suppl 1):S443-S474. DOI: 10.1016/j.ajt.2023.02.010. View

17.

Konoeda C, Sato M, Nakajima J . [Extracorporeal Membrane Oxygenation in Lung Transplantation]. Kyobu Geka. 2022; 75(4):254-258. View

18.

Hoshikawa Y, Okada Y, Ashikari J, Matsuda Y, Niikawa H, Noda M . Medical consultant system for improving lung transplantation opportunities and outcomes in Japan. Transplant Proc. 2015; 47(3):746-50. DOI: 10.1016/j.transproceed.2014.12.041. View

19.

Valapour M, Lehr C, Schladt D, Smith J, Goff R, Mupfudze T . OPTN/SRTR 2021 Annual Data Report: Lung. Am J Transplant. 2023; 23(2 Suppl 1):S379-S442. PMC: 9970343. DOI: 10.1016/j.ajt.2023.02.009. View

20.

Moser B, Jaksch P, Taghavi S, Murakozy G, Lang G, Hager H . Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg. 2017; 53(1):178-185. PMC: 5848802. DOI: 10.1093/ejcts/ezx212. View